SANOFICONR

Sanofi Consumer Healthcare India Share Price

₹4,814.20 -11.2 (-0.23%)

21 Nov, 2024 14:21

SIP TrendupStart SIP in SANOFICONR

Start SIP

Performance

  • Low
  • ₹4,703
  • High
  • ₹4,842
  • 52 Week Low
  • ₹4,212
  • 52 Week High
  • ₹5,375
  • Open Price₹4,801
  • Previous Close₹4,825
  • Volume25,344

Investment Returns

  • Over 1 Month -0.2%
  • Over 3 Month + 27.61%
  • Over 6 Month + 27.61%
  • Over 1 Year + 27.61%
SIP Lightning

Smart Investing Starts Here Start SIP with Sanofi Consumer Healthcare India for Steady Growth!

Invest Now

Sanofi Consumer Healthcare India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 11,087
  • P/B Ratio
  • 6522
  • Average True Range
  • 143.37
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -40.05
  • RSI
  • 46.68
  • MFI
  • 20.67

Sanofi Consumer Healthcare India Financials

Sanofi Consumer Healthcare India Technicals

EMA & SMA

Current Price
₹4,814.20
-11.2 (-0.23%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 9
  • 20 Day
  • ₹4,869.68
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

4831.48 Pivot Speed
  • R3 4,929.02
  • R2 4,898.53
  • R1 4,861.97
  • S1 4,794.92
  • S2 4,764.43
  • S3 4,727.87

What's your outlook on Sanofi Consumer Healthcare India?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Sanofi Consumer Healthcare is a leading provider of over-the-counter (OTC) healthcare products, offering solutions for pain relief, allergies, digestion, and vitamins. Known for brands like Allegra, Combiflam, and Enterogermina, it enhances everyday health and wellness.

Sanofi Consumer Healthcare India Ltd has an operating revenue of Rs. 635.80 Cr. on a trailing 12-month basis. Pre-tax margin of 0% needs improvement, ROE of 0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 36 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 71 indicates it belongs to a poor industry group of Medical-Long-term Care and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sanofi Consumer Healthcare India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results

Sanofi Consumer Healthcare India F&O

Sanofi Consumer Healthcare India Shareholding Pattern

60.4%
13.06%
10.75%
5.22%
0%
7.53%
3.04%

About Sanofi Consumer Healthcare India

  • NSE Symbol
  • SANOFICONR
  • BSE Symbol
  • 544250
  • Managing Director
  • Mr. Himanshu Bakshi
  • ISIN
  • INE0UOS01011

Similar Stocks to Sanofi Consumer Healthcare India

Sanofi Consumer Healthcare India FAQs

Sanofi Consumer Healthcare India share price is ₹4,814 As on 21 November, 2024 | 14:07

The Market Cap of Sanofi Consumer Healthcare India is ₹11087.4 Cr As on 21 November, 2024 | 14:07

The P/E ratio of Sanofi Consumer Healthcare India is As on 21 November, 2024 | 14:07

The PB ratio of Sanofi Consumer Healthcare India is 6522 As on 21 November, 2024 | 14:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23